Alirocumab and Lipid Levels, Inflammatory Biomarkers, Metabolomics, and Safety in Patients Receiving Maintenance Dialysis: The ALIrocumab in DIALysis Study (A Phase 3 Trial to Evaluate the Efficacy and Safety of Biweekly Alirocumab in Patients on a Stable Dialysis Regimen)

Alirocumab 与维持性透析患者的血脂水平、炎症生物标志物、代谢组学和安全性：ALIrocumab in DIALysis 研究（一项评估每两周一次 Alirocumab 对接受稳定透析方案患者的疗效和安全性的 3 期试验）